トランスフォーミング増殖因子ベータ1市場2021: メーカー、地域（ヨーロッパ、アジア太平洋、北アメリカ、南アメリカ）、タイプとアプリケーション、2028年までの予測 (アップデート版あり)

このレポートには、最新の市場図、統計、データが含まれています

ライセンスを選択

概要
目次

トランスフォーミング増殖因子ベータ1の市場は、今後8年間で約X.X％のCAGRで成長すると推定されており、2021年のX.X百万米ドルから、2028年にはX.X百万米ドルに達するでしょう。
さまざまな種類のトランスフォーミング増殖因子ベータ1、下流の消費分野、および世界中のさまざまな地域や国の競争環境のほとんどのセグメント化された消費および販売データを提供することを目的として、このレポートは一次および二次の信頼できるソースからの最新の市場データを分析します。

レポートはまた、推進要因、抑制要因などの最新の市場のダイナミクス、および合併、買収、投資などの業界ニュースを追跡します。市場規模（価値と量）、市場シェア、種類別の成長率、アプリケーションを提供し、定性的手法と定量的手法の両方を組み合わせて、さまざまな地域または国でミクロおよびマクロの予測を行います。
レポートは、市場を理解し、それに応じて事業拡大のための戦略を立てるのに役立ちます。戦略分析では、マーケティングチャネルと市場のポジショニングから潜在的な成長戦略までの洞察を提供し、トランスフォーミング増殖因子ベータ1業界の新規参入者または既存の競合他社に詳細な分析を提供します。

メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG

タイプによる市場細分化：
ピルフェニドン
Galunisertib
他人
アプリケーションによる市場細分化：
IPF
癌
他人

レポートにおける国レベルのセグメンテーション：
アメリカ
日本
インド
ドイツ
英国
フランス
イタリア
スペイン
ポーランド
ロシア
中国
インドネシア
タイ
フィリピン
マレーシア
シンガポール
ベトナム
ブラジル
サウジアラビア
アラブ首長国連邦
カタール
バーレーン

Table of Contents

1 Study Coverage
1.1 Transforming Growth Factor Beta 1 Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Product
1.4.2 Pirfenidone
1.4.3 Galunisertib
1.4.4 Others
1.5 Market by End User
1.5.1 Global Transforming Growth Factor Beta 1 Market Size Growth Rate by End User
1.5.2 IPF
1.5.3 Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Transforming Growth Factor Beta 1 Market Size
2.1.1 Global Transforming Growth Factor Beta 1 Revenue 2015-2028
2.1.2 Global Transforming Growth Factor Beta 1 Sales 2015-2028
2.2 Transforming Growth Factor Beta 1 Growth Rate by Regions
2.2.1 Global Transforming Growth Factor Beta 1 Sales by Regions
2.2.2 Global Transforming Growth Factor Beta 1 Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Transforming Growth Factor Beta 1 Sales by Manufacturers
3.1.1 Transforming Growth Factor Beta 1 Sales by Manufacturers
3.1.2 Transforming Growth Factor Beta 1 Sales Market Share by Manufacturers
3.1.3 Global Transforming Growth Factor Beta 1 Market Concentration Ratio (CR5 and HHI)
3.2 Transforming Growth Factor Beta 1 Revenue by Manufacturers
3.2.1 Transforming Growth Factor Beta 1 Revenue by Manufacturers (2015-2020)
3.2.2 Transforming Growth Factor Beta 1 Revenue Share by Manufacturers (2015-2020)
3.3 Transforming Growth Factor Beta 1 Price by Manufacturers
3.4 Transforming Growth Factor Beta 1 Manufacturing Base Distribution, Product Types
3.4.1 Transforming Growth Factor Beta 1 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transforming Growth Factor Beta 1 Product Type
3.4.3 Date of International Manufacturers Enter into Transforming Growth Factor Beta 1 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Transforming Growth Factor Beta 1 Sales by Product
4.2 Global Transforming Growth Factor Beta 1 Revenue by Product
4.3 Transforming Growth Factor Beta 1 Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Transforming Growth Factor Beta 1 Breakdown Data by End User

6 North America
6.1 North America Transforming Growth Factor Beta 1 by Countries
6.1.1 North America Transforming Growth Factor Beta 1 Sales by Countries
6.1.2 North America Transforming Growth Factor Beta 1 Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Transforming Growth Factor Beta 1 by Product
6.3 North America Transforming Growth Factor Beta 1 by End User

7 Europe
7.1 Europe Transforming Growth Factor Beta 1 by Countries
7.1.1 Europe Transforming Growth Factor Beta 1 Sales by Countries
7.1.2 Europe Transforming Growth Factor Beta 1 Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Transforming Growth Factor Beta 1 by Product
7.3 Europe Transforming Growth Factor Beta 1 by End User

8 Asia Pacific
8.1 Asia Pacific Transforming Growth Factor Beta 1 by Countries
8.1.1 Asia Pacific Transforming Growth Factor Beta 1 Sales by Countries
8.1.2 Asia Pacific Transforming Growth Factor Beta 1 Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Transforming Growth Factor Beta 1 by Product
8.3 Asia Pacific Transforming Growth Factor Beta 1 by End User

9 Central & South America
9.1 Central & South America Transforming Growth Factor Beta 1 by Countries
9.1.1 Central & South America Transforming Growth Factor Beta 1 Sales by Countries
9.1.2 Central & South America Transforming Growth Factor Beta 1 Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Transforming Growth Factor Beta 1 by Product
9.3 Central & South America Transforming Growth Factor Beta 1 by End User

10 Middle East and Africa
10.1 Middle East and Africa Transforming Growth Factor Beta 1 by Countries
10.1.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Countries
10.1.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Transforming Growth Factor Beta 1 by Product
10.3 Middle East and Africa Transforming Growth Factor Beta 1 by End User

11 Company Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Company Business Overview
11.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Transforming Growth Factor Beta 1 Products Offered
11.1.5 Roche Recent Development
11.2 Shionogi Ltd
11.2.1 Shionogi Ltd Company Details
11.2.2 Company Business Overview
11.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Products Offered
11.2.5 Shionogi Ltd Recent Development
11.3 Acceleron Pharma Inc
11.3.1 Acceleron Pharma Inc Company Details
11.3.2 Company Business Overview
11.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Products Offered
11.3.5 Acceleron Pharma Inc Recent Development
11.4 Genzyme Corp
11.4.1 Genzyme Corp Company Details
11.4.2 Company Business Overview
11.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Products Offered
11.4.5 Genzyme Corp Recent Development
11.5 Isarna Therapeutics GmbH
11.5.1 Isarna Therapeutics GmbH Company Details
11.5.2 Company Business Overview
11.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Products Offered
11.5.5 Isarna Therapeutics GmbH Recent Development
11.6 Scholar Rock
11.6.1 Scholar Rock Company Details
11.6.2 Company Business Overview
11.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Scholar Rock Transforming Growth Factor Beta 1 Products Offered
11.6.5 Scholar Rock Recent Development
11.7 Sirnaomics Inc
11.7.1 Sirnaomics Inc Company Details
11.7.2 Company Business Overview
11.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Products Offered
11.7.5 Sirnaomics Inc Recent Development
11.8 Eli Lilly and Co
11.8.1 Eli Lilly and Co Company Details
11.8.2 Company Business Overview
11.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Products Offered
11.8.5 Eli Lilly and Co Recent Development
11.9 Formation Biologics Inc
11.9.1 Formation Biologics Inc Company Details
11.9.2 Company Business Overview
11.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Products Offered
11.9.5 Formation Biologics Inc Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Company Business Overview
11.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis AG Transforming Growth Factor Beta 1 Products Offered
11.10.5 Novartis AG Recent Development

12 Future Forecast
12.1 Transforming Growth Factor Beta 1 Market Forecast by Regions
12.1.1 Global Transforming Growth Factor Beta 1 Sales Forecast by Regions 2021-2028
12.1.2 Global Transforming Growth Factor Beta 1 Revenue Forecast by Regions 2021-2028
12.2 Transforming Growth Factor Beta 1 Market Forecast by Product
12.2.1 Global Transforming Growth Factor Beta 1 Sales Forecast by Product 2021-2028
12.2.2 Global Transforming Growth Factor Beta 1 Revenue Forecast by Product 2021-2028
12.3 Transforming Growth Factor Beta 1 Market Forecast by End User
12.4 North America Transforming Growth Factor Beta 1 Forecast
12.5 Europe Transforming Growth Factor Beta 1 Forecast
12.6 Asia Pacific Transforming Growth Factor Beta 1 Forecast
12.7 Central & South America Transforming Growth Factor Beta 1 Forecast
12.8 Middle East and Africa Transforming Growth Factor Beta 1 Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transforming Growth Factor Beta 1 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer